News Releases

2021 2020 2019 2018 2017 2016 2015 2014 2013
Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer (mCRPC) Study
September 21, 2021
Zenith Epigenetics Announces a Publication in the Journal of Cancer Gene Therapy with Compelling Data for the Treatment of ER-Positive Breast Cancer Patients
August 17, 2021
Zenith Epigenetics Announces a Publication Highlighting the Role of ZEN-3694 in Overcoming Resistance to Therapies in Metastatic Castration-Resistant Prostate Cancer
June 24, 2021
Zenith Epigenetics Announces Clinical Collaboration with Astellas
April 22, 2021
Zenith Epigenetics Announces Dosing of First mCRPC Patient with a Combination of ZEN-3694 + Merck’s Immune Check Point Inhibitor KEYTRUDA
March 15, 2021

About

Science & Epigenetics

Programs

Newsroom

Contact

© 2021 zenithepigenetics | Legal | Privacy

Bookmark and Share